Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adam S Lauring

Showing results (111-120 of 162) with videos related to

Pageof 17
Sort By:
The Journal of Infectious Diseases|January 8, 2025
Effectiveness of mRNA COVID-19 Vaccines and Hybrid Immunity in Preventing SARS-CoV-2 Infection and Symptomatic COVID-19 Among Adults in the United StatesLeora R Feldstein, Jasmine Ruffin, Ryan E Wiegand, et al.
Influenza and Other Respiratory Viruses|July 12, 2022
Ascertainment of vaccination status by self-report versus source documentation: Impact on measuring COVID-19 vaccine effectivenessMeagan Stephenson, Samantha M Olson, Wesley H Self, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 3, 2022
Vaccine Effectiveness Against Influenza A(H3N2)-Associated Hospitalized Illness: United States, 2022Mark W Tenforde, Manish M Patel, Nathaniel M Lewis, et al.
Journal of the Pediatric Infectious Diseases Society|December 10, 2024
Protection From COVID-19 Vaccination and Prior SARS-CoV-2 Infection Among Children Aged 6 Months-4 Years, United States, September 2022-April 2023Leora R Feldstein, Jasmine Ruffin, Ryan Wiegand, et al.
JAMA|February 6, 2024
Effectiveness of Bivalent mRNA COVID-19 Vaccines in Preventing SARS-CoV-2 Infection in Children and Adolescents Aged 5 to 17 YearsLeora R Feldstein, Amadea Britton, Lauren Grant, et al.
JAMA|January 26, 2023
Household Transmission of Influenza A Viruses in 2021-2022Melissa A Rolfes, H Keipp Talbot, Huong Q McLean, et al.
Medrxiv : the Preprint Server for Health Sciences|February 9, 2026
Genomic surveillance of human metapneumovirus in the United States, 2010 - 2025Emily E Bendall, William J Fitzsimmons, Weronika Damek Valvano, et al.
The Journal of Infectious Diseases|May 6, 2026
Genomic surveillance of human metapneumovirus in the United States, 2010-2025Emily E Bendall, William J Fitzsimmons, Weronika Damek Valvano, et al.
BMJ (Clinical Research Ed.)|October 11, 2022
Vaccine effectiveness of primary series and booster doses against covid-19 associated hospital admissions in the United States: living test negative design studyKatherine Adams, Jillian P Rhoads, Diya Surie, et al.
JAMA Network Open|April 1, 2025
Patient- and Community-Level Characteristics Associated With Respiratory Syncytial Virus VaccinationDiya Surie, Katharine A Yuengling, Basmah Safdar, et al.
Pageof 17

Showing results (111-120 of 162) with videos related to

Sort By:
Pageof 17
The Journal of Infectious Diseases|January 8, 2025
Effectiveness of mRNA COVID-19 Vaccines and Hybrid Immunity in Preventing SARS-CoV-2 Infection and Symptomatic COVID-19 Among Adults in the United StatesLeora R Feldstein, Jasmine Ruffin, Ryan E Wiegand, et al.
Influenza and Other Respiratory Viruses|July 12, 2022
Ascertainment of vaccination status by self-report versus source documentation: Impact on measuring COVID-19 vaccine effectivenessMeagan Stephenson, Samantha M Olson, Wesley H Self, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 3, 2022
Vaccine Effectiveness Against Influenza A(H3N2)-Associated Hospitalized Illness: United States, 2022Mark W Tenforde, Manish M Patel, Nathaniel M Lewis, et al.
Journal of the Pediatric Infectious Diseases Society|December 10, 2024
Protection From COVID-19 Vaccination and Prior SARS-CoV-2 Infection Among Children Aged 6 Months-4 Years, United States, September 2022-April 2023Leora R Feldstein, Jasmine Ruffin, Ryan Wiegand, et al.
JAMA|February 6, 2024
Effectiveness of Bivalent mRNA COVID-19 Vaccines in Preventing SARS-CoV-2 Infection in Children and Adolescents Aged 5 to 17 YearsLeora R Feldstein, Amadea Britton, Lauren Grant, et al.
JAMA|January 26, 2023
Household Transmission of Influenza A Viruses in 2021-2022Melissa A Rolfes, H Keipp Talbot, Huong Q McLean, et al.
Medrxiv : the Preprint Server for Health Sciences|February 9, 2026
Genomic surveillance of human metapneumovirus in the United States, 2010 - 2025Emily E Bendall, William J Fitzsimmons, Weronika Damek Valvano, et al.
The Journal of Infectious Diseases|May 6, 2026
Genomic surveillance of human metapneumovirus in the United States, 2010-2025Emily E Bendall, William J Fitzsimmons, Weronika Damek Valvano, et al.
BMJ (Clinical Research Ed.)|October 11, 2022
Vaccine effectiveness of primary series and booster doses against covid-19 associated hospital admissions in the United States: living test negative design studyKatherine Adams, Jillian P Rhoads, Diya Surie, et al.
JAMA Network Open|April 1, 2025
Patient- and Community-Level Characteristics Associated With Respiratory Syncytial Virus VaccinationDiya Surie, Katharine A Yuengling, Basmah Safdar, et al.
Pageof 17